| MINERVA NEUROSCIENCES |
| USA |
| Gesundheit |
| US6033802058 / A3DMH5 |
| 4MNA (Frankfurt) / NERV (NASDAQ) |
| FRA:4MNA, ETR:4MNA, 4MNA:GR, NASDAQ:NERV |
| - |
| https://www.minervaneuros.. |
|
Minerva Neurosciences Inc. is a biopharmaceutical ..
>Volltext.. |
| 16.03 Mio. EUR |
| 54.06 Mio. EUR |
| - |
| -13.92 Mio. EUR |
| 9.68 Mio. EUR |
| 1.28 EUR |
| 51.7 Mio. EUR |
| 13.22 Mio. EUR |
| -13.47 Mio. EUR |
| 6.07 |
| - |
| - |
| - |
| - |
| - |
| - |
| MINERVA NEUROSCIENCES, MINERVA NEURO, MINERVA NEUROSCIENCE |
| 22.10.25 |
|